Immunological and Viral Parameters in Patients Receiving Anti-epileptic Drugs

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

December 31, 2015

Conditions
EpilepsyDrug Hypersensitivity Syndrome
Interventions
DRUG

anti-epileptic drug

Patient who initiate anti-epileptic drug (sodium valproate, divalproate sodium, valpromide, lamotrigine, carbamazepine, oxcarbazepine, eslicarbazepine acetate)

BIOLOGICAL

Blood sampling

Blood sampling is done for Patient who initiate anti-epileptic drug (sodium valproate, divalproate sodium, valpromide, lamotrigine, carbamazepine, oxcarbazepine, eslicarbazepine acetate)

Trial Locations (1)

76031

Rouen University Hospital, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT02556320 - Immunological and Viral Parameters in Patients Receiving Anti-epileptic Drugs | Biotech Hunter | Biotech Hunter